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The chromatograms from pregnancy urine are shown in Fig. 3 . Here the GB readings are relatively high and GA relatively low.
The chromatograms of 2 urines from women with functional amenorrhoea (Fig. 4) show fairly low Tesponses with both ninhydrin and orcinol. One patient was treated with 1,000 units of a chorionic gonadotrophin preparation (Antuitrin S) and her chromatogram shows a high GB fraction with .orcinol and resembles a pregnancy chromatogram. It will be seen that the results of the chemical analysis correspond with the biological findings. In each case GA is high in the normal cycle and the menopause, and GB is high in pregnancy and after the administration of chorionic gonadotrophins. We have not yet demonstrated any separation of follicle-stimulating and luteinizing substances biologically but investigations are in progress to establish this with hypophysectomized lats. The contrasting chromatographic patterns in these different conditions lead one to hope, however, that by the selection of suitable reagents it will be possible to develop a chemical test for the diagnosis of pregnancy. MoreoveL the procedure may be applied for the measurement of the relative concentration of the gonadotrophins. become ever more apparent, but elucidation has to a great extent awaited advance3 in mathematics, physics and chemistry. The present century has seen spectacular advances in organic chemistryincluding the isolation, identification and partial synthesis of a group of phenanthrene derivatives-the steroids-and, furthermore, the recognition that many of the active principles secreted by the endocrine glands fall within that group. Already, significant progress has been made in the study of the biochemistry of the steroid hormones and of their metabolic products. As this new field is developed the clinical endocrinologist and the biochemist must join in an attempt to bridge the gap between the results of these basic studies and the solution of urgent clinical problems. It may be that the extent of this gap is not clearly appreciated and yet it must be apparent that a host of untested assumptions are involved in almost all attempts to derive diagnostic or therapeutic implications from existing experimental data. It is not enough to hope that the advancing frontier of science will overtake the everwidening horizon of clinical medicine. Positive action must be taken to bridge the gap in certain areas.
It may be timely, therefore, to consider the types of study which are in progress in steroid biochemistry with respect to their applicability to the needs of the clinical endocrinologist.
For the purpose of discussion these may be divided into two categories.
(1) Urinalysis for steroids of endogenous origin.-In this type of study, no steroid is administered and the steroid pattern in the urine reflects the endogenous secretion of the parent hormones. It is obvious that the scope of such work is seriously limited by lack of knowledge of intermediary metabolism. Thus it is probable that too many biochemical changes intervene between the moment of secretion of the hormone and the urinary excretion of a metabolite to merit the deduction of the amount of hormone secreted from a knowledge of the amount of metabolite excreted. None the less, such information may be of real diagnostic or prognostic value. The physician is familiar with the usefulness and limitations of quantitative urinalysis for the presence of the neutral 17-ketosteroids or of the progesterone metabolite, pregnanediol. There is great need for improvements in methodologynotably in the specificity of methods for the determination of steroids of adrenocortical origin and the sensitivity of methods for the determination of the urinary cestrogens.
An advance of especial interest to the clinical endocrinologist has resulted from the application of infra-red spectroscopy to this problem. Using this technique, Dobriner and his colleagues were enabled to study steroid patterns in greater detail and observed qualitative and quantitative differences in the excretion of individual steroids in groups of human subjects in health and disease. Thus, one steroid, I l-hydroxyetiocholanolone, is excreted by a significant number of patients with adrenal hyperplasia or neoplastic disease. Similarly, another compound-17-hydroxypregnanolonewas isolated from the urine of certain cases of rheumatoid arthritis and consistently from the urine of patients with adrenal hyperplasia . This steroid was isolated from the urine of human subjects receiving the adrenocorticotrophic hormone, but was not detected in the urine of any of 28 healthy subjects. These observations led Dobriner to conclude that, in the cases of neoplasia or arthritis which were investigated by his group, there was abnormal adrenal function or, alternatively, altered metabolism of the adrenocortical hormones. The fact that these abnormal metabolites were excreted in the urine of patients with adrenal hyperplasia and, after stimulation of the adrenal cortex, appeared to favour location of the disorder in the gland itself.
(2) Attempts to study the intermediary metabolism of the steroid hormones.-In these studies an attempt is made to elucidate the manner in which the steroid molecule is handled by the cell, the organ or the total living organism. Thus information is obtained from in vitro experiments with homogenates and tissue slices, from the perfusion of isolated glands or target organs and from metabolic studies in animals and in the human subject.
The in vitro and perfusion studies are yielding information of great value concerning the metabolic changes which are likely to occur, and appear to offer the most promising route to an understanding of the chemical basis of the biological action of the steroid hormones. They are exemplified by recent work on the metabolism of the Cl9 steroids by individual tissues (Samuels, 1950 (Samuels, , 1952 and by the studies of Pincus and his colleagues who use perfusion techniques to unravel the complexities of steroid biogenesis (Hechter et al., 1951) .
The investigation of steroid metabolism in the total living organism is of especial importance since evidence may be obtained indicating which of the probabilities suggested by the in vitro or perfusion studies actually occur. It must be recognized, however, that the study of steroid metabolism in the human subject is at a very early stage of development. Quantitative methods of urinalysis are still imperfect, it is difficult to assess the amount of steroid to which the organism is likely to be subjected under physiological conditions, the efficiency of absorption of the administered steroid is an important variable and ideal clinical material is rarely available. Frequently the choice lies between the healthy animal and the diseased human subject. Experiments are reported in which what appear to be very large amounts of steroid are administered to patients in the terminal stages of some chronic disease. The physician may well be baffled by data which emerge from this interplay of pharmacology and pathology. Despite these difficulties oftechnique and interpretation much has been learned from studies in which a steroid hormone is administered and the urine is analysed for a suspected metabolite. These advances have been reviewed elsewhere (Lieberman and Dobriner, 1951) . Further progress in this phase of the work should result from studies with isotopically labelled steroids (Gallagher et al., 1951) . But it will be apparent that the main factor limiting their scope is the fact that the data are derived from urinalysis and that consequently the light shed upon the processes of intermediary metabolism is somewhat indirect. For this reason attention has been turned to methods for the quantitative determination of steroids in the blood or tissues of the body itself.
A high degree of sensitivity and specificity will be required of such methods but that the task may not be impossible is shown by the development of such a method for the quantitative determination of progesterone in peripheral blood (Butt, et al, 1951) and of a method for the quantitative determination of circulating 17-hydroxycorticosteroids (Nelson and Samuels, 1952) . The type of study made possible by this approach is exemplified by a recent report upon the fate of testosterone administered intravenously to human subjects in health and with hepatic dysfunction (West, Tyler and Samuels, 1951) and during the past year I have been privileged to spend several months with Professor Samuels and his group at the University of Utah and to apply some of the principles which they have evolved to a study of the metabolism of intravenously administered progesterone (Sommerville and Bigler, 1952) .
The aim of this work was to develop a micro-method for the determination of progesterone, pregnanediol-in the free form and as the glucuronide-and, if possible, other metabolites of the hormone, in a single sample of peripheral venous blood (30 ml.). Although the experiments are at a very preliminary stage, considerable progess has been made with respect to determination of the metabolite in laked blood before and after hydrolysis by the enzyme (-glucuronidase. Ether-chloroform extracts are purified by chromatography on alumina and, to ensure the maximum degree of specificity, further purification is necessary before application of the relatively non-specific sulphuric acid reaction. Two metabolic experiments are illustrated in Figs. 1 and 2. Fig. 1 shows the levels of circulating metabolite during and after the intravenous infusion of the hormone (in a solution of 25 % human serum albumin) to a young man. The level of pregnanediol is expressed in microgranis per blood sample. Fig. 2 shows a similar experiment in a male dog. In this case the determinations were carried out on 20 ml. samples and the result is expressed in micrograms per 100 ml. It will be seen that in both experiments there is evidence of very rapid reduction of the hormone to the metabolite, manifested by the rapid rise in blood level during the infusion. In the human experiment it is especially significant that the level of pregnanediol conjugated as glucuronide is at its maximum at the end-point of the infusion. Following the infusion there is rapid clearance of the steroid from the circulation. Further what extent further metabolism of the metabolite.
The micro-method has been applied to the determination of microgram amounts of pregnanediol in urine and the metabolite estimated in hourly samples obtained from human subjects receiving ther hormone. The method has also been used for the determination of the steroid in hepatic tissue obtained by laparotomy.
These experiments emphasize our lack of information concerning the mechanism of transport of steroids in the blood stream. Little is known about the factors influencing the dynamic interaction of steroid and protein during transport or about the significance of the conjugation of steroids as glucuronides or sulphates. None the less this recent trend should provide encouragement to the clinical endocrinologist in that it offers the hope of more direct information upon steroid metabolism in human subjects. New techniques should be applicable to the determination of circulating steroids of endogenous Vigin and would afford an opportunity for a study of arteriovenous differences in situ. It should be-,ossible to obtain information concerning the renal clearance of metabolites in health and disease .and this information will aid the physician in the interpretation of data which have already beeas fobtained by urinalysis.
